# Accu-Chek missiOn: SMBG in Patients With diAbetes on inSulin Study (COMPASS) - Multiple Center, Open, and Non-randomized Study

Study · id `cardio:ct-nct01130480` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01130480](<https://clinicaltrials.gov/study/NCT01130480>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01130480

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 833 participants.

## Technical summary

Registry record NCT01130480. Allocation not applicable; no masking; primary purpose diagnostic. Start 2010-05-31 (actual); primary completion 2012-03-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 833 participants (enrolled count; ClinicalTrials.gov record NCT01130480, source copy `cardio:ctgov-nct01130480-2017-04-04`, retrieved 2026-10-26)
- Started: 2010-05-31 (actual) (ClinicalTrials.gov record NCT01130480, source copy `cardio:ctgov-nct01130480-2017-04-04`, retrieved 2026-10-26)
- Primary completion: 2012-03-31 (actual) (ClinicalTrials.gov record NCT01130480, source copy `cardio:ctgov-nct01130480-2017-04-04`, retrieved 2026-10-26)
- Completion: 2012-03-31 (actual) (ClinicalTrials.gov record NCT01130480, source copy `cardio:ctgov-nct01130480-2017-04-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01130480, source copy `cardio:ctgov-nct01130480-2017-04-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01130480-2017-04-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Accu-Chek missiOn: SMBG in Patients With diAbetes on inSulin Study (COMPASS) - Multiple Center, Open, and Non-randomized Study
- Condition: Diabetes Mellitus Type 2
- Intervention (Device): Accu-Chek Integra Glucometer
- Lead sponsor: Hoffmann-La Roche
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Hoffmann-La Roche (`cardio:org-hoffmann-la-roche`)

## Provenance

Content hash: e760aba2179f4e42ccf369e63a31b5a3b309d687191a770fc47c89fe75a43980
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
